BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32294625)

  • 21. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
    Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
    IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of transcription factor RUNX2 in lung adenocarcinoma and its latent transcriptional regulating mechanism.
    Yang DP; Huang WY; Chen G; Chen SW; Yang J; He RQ; Huang SN; Gan TQ; Ma J; Yang LJ; Song JH; Mo JX; Tang ZQ; Li CB; Zhou HF; Kong JL
    Comput Biol Chem; 2020 Dec; 89():107383. PubMed ID: 33032037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STAT1-induced upregulation of LINC00467 promotes the proliferation migration of lung adenocarcinoma cells by epigenetically silencing DKK1 to activate Wnt/β-catenin signaling pathway.
    Yang J; Liu Y; Mai X; Lu S; Jin L; Tai X
    Biochem Biophys Res Commun; 2019 Jun; 514(1):118-126. PubMed ID: 31027730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma.
    Ren ZP; Hou XB; Tian XD; Guo JT; Zhang LB; Xue ZQ; Deng JQ; Zhang SW; Pan JY; Chu XY
    FEBS Open Bio; 2019 Feb; 9(2):315-327. PubMed ID: 30761256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma.
    Bai Y; Xiong L; Zhu M; Yang Z; Zhao J; Tang H
    Cancer Biomark; 2019; 24(3):371-382. PubMed ID: 30883337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression.
    Sun T; Zhang K; Li W; Liu Y; Pangeni RP; Li A; Arvanitis L; Raz DJ
    Cell Commun Signal; 2022 Sep; 20(1):147. PubMed ID: 36123698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P2RX7B is a new theranostic marker for lung adenocarcinoma patients.
    Benzaquen J; Dit Hreich SJ; Heeke S; Juhel T; Lalvee S; Bauwens S; Saccani S; Lenormand P; Hofman V; Butori M; Leroy S; Berthet JP; Marquette CH; Hofman P; Vouret-Craviari V
    Theranostics; 2020; 10(24):10849-10860. PubMed ID: 33042257
    [No Abstract]   [Full Text] [Related]  

  • 30. USP4 expression independently predicts favorable survival in lung adenocarcinoma.
    Zhong M; Jiang Q; Jin R
    IUBMB Life; 2018 Jul; 70(7):670-677. PubMed ID: 29667299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
    Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
    Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeability.
    Li Y; Zhang H; Fan L; Mou J; Yin Y; Peng C; Chen Y; Lu H; Zhao L; Tao Z; Chen J; Wang Y; Qi X; Huang R; Ren J
    Oncogene; 2020 Apr; 39(17):3473-3488. PubMed ID: 32108166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
    Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. USP22 Functions as an Oncogenic Driver in Prostate Cancer by Regulating Cell Proliferation and DNA Repair.
    McCann JJ; Vasilevskaya IA; Poudel Neupane N; Shafi AA; McNair C; Dylgjeri E; Mandigo AC; Schiewer MJ; Schrecengost RS; Gallagher P; Stanek TJ; McMahon SB; Berman-Booty LD; Ostrander WF; Knudsen KE
    Cancer Res; 2020 Feb; 80(3):430-443. PubMed ID: 31740444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis.
    Wang Y; Fu J; Wang Z; Lv Z; Fan Z; Lei T
    Cancer Biomark; 2019; 25(4):313-324. PubMed ID: 31322548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression levels and co‑targets of miRNA‑126‑3p and miRNA‑126‑5p in lung adenocarcinoma tissues: Αn exploration with RT‑qPCR, microarray and bioinformatic analyses.
    Chen P; Gu YY; Ma FC; He RQ; Li ZY; Zhai GQ; Lin X; Hu XH; Pan LJ; Chen G
    Oncol Rep; 2019 Feb; 41(2):939-953. PubMed ID: 30535503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma.
    Bai Z; Du Y; Cong L; Cheng Y
    Gene; 2020 Oct; 758():144960. PubMed ID: 32687947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel microRNA signature for pathological grading in lung adenocarcinoma based on TCGA and GEO data.
    Yang Z; Yin H; Shi L; Qian X
    Int J Mol Med; 2020 May; 45(5):1397-1408. PubMed ID: 32323746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma.
    Li L; Feng T; Qu J; Feng N; Wang Y; Ma RN; Li X; Zheng ZJ; Yu H; Qian B
    Genet Test Mol Biomarkers; 2018 Jan; 22(1):20-28. PubMed ID: 29297704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. USP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu J; Yang D; Zhang H; Liu W; Zhao Y; Lu H; Meng Q; Pang H; Chen X; Liu Y; Cai L
    Lung Cancer; 2015 Jun; 88(3):239-45. PubMed ID: 25907317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.